Chronic myelogenous leukemia (CML) is a myeloproliferative disorder characterized at the molecular level by the expression of Bcr-abl, a 210-kDa fusion protein with deregulated tyrosine kinase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback